|
XRCC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.32907051820075E-15 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11969988836336E-10 |
| Normal-vs-Stage2 |
3.577600E-02 |
| Normal-vs-Stage3 |
3.74160000000678E-05 |
| Normal-vs-Stage4 |
1.439000E-01 |
| Stage1-vs-Stage2 |
2.825400E-01 |
| Stage1-vs-Stage3 |
7.842400E-03 |
| Stage1-vs-Stage4 |
2.546200E-01 |
| Stage2-vs-Stage3 |
6.350200E-01 |
| Stage2-vs-Stage4 |
4.388400E-01 |
| Stage3-vs-Stage4 |
5.301200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.50659534531906E-11 |
| Normal-vs-AfricanAmerican |
1.774850E-04 |
| Normal-vs-Asian |
1.399210E-01 |
| Caucasian-vs-AfricanAmerican |
8.697400E-01 |
| Caucasian-vs-Asian |
9.017400E-01 |
| AfricanAmerican-vs-Asian |
9.428000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.30970001510633E-09 |
| Normal-vs-Female |
2.5656999969037E-08 |
| Male-vs-Female |
7.241300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.902300E-03 |
| Normal-vs-Extreme_Weight |
1.41869999970012E-07 |
| Normal-vs-Obese |
1.9539600000007E-05 |
| Normal-vs-Extreme_Obese |
6.564200E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.317390E-01 |
| Normal_Weight-vs-Obese |
9.980000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.985900E-02 |
| Extreme_Weight-vs-Obese |
1.703610E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.429600E-02 |
| Obese-vs-Extreme_Obese |
1.777090E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.035700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.29759999914592E-08 |
| Normal-vs-Age(61-80Yrs) |
3.9127999995614E-07 |
| Normal-vs-Age(81-100Yrs) |
5.246400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.607600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.557800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.208200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.286050E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.716000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.555200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.22960000356909E-10 |
| Normal-VS-Type2 PRCC |
2.417200E-03 |
| Normal-VS-KIRP CIMP |
7.784900E-03 |
| Normal-VS-Unclassified PRCC |
2.82659999994994E-06 |
| Type1 PRCC-VS-Type2 PRCC |
6.287200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.740300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.022400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.023200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.820600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.313600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.12370000000273E-05 |
| Normal-vs-N1 |
2.283400E-03 |
| Normal-vs-N2 |
1.224560E-01 |
| N0-vs-N1 |
1.231530E-02 |
| N0-vs-N2 |
3.946100E-02 |
| N1-vs-N2 |
5.507800E-01 |
|
|
